— CO-FOUNDER
John Mauldin
Macroeconomic strategist, bestselling author, and the investor who bet on longevity.
PUBLISHED
4× New York Times Bestselling Author
NEWSLETTER
Thoughts from the Frontline — 1M+ weekly readers
CONFERENCE
Host, Strategic Investment Conference
“My dad died from dementia. I watched him, and many of his brothers and sisters, lose themselves to memory loss. I wanted something different for myself, and I found it in Therapeutic Plasma Exchange.”
John Mauldin, on why he co-founded Lifespan Edge
About John Mauldin
Three decades of reading the future — and acting on it.
For more than 30 years, John Mauldin has made his career doing one thing: seeing what’s coming before the consensus catches up. As publisher of Thoughts from the Frontline — one of the most widely read investment newsletters in the world, reaching over a million readers weekly — he has built a reputation for translating complex macroeconomic forces into clear, actionable thinking.
A four-time New York Times bestselling author, Mauldin has written six books on global economics and investing, including Endgame, Code Red, and Bull’s Eye Investing. He is co-founder of Mauldin Economics and host of the Strategic Investment Conference, an annual gathering that draws some of the most respected minds in global finance. Through Transformative Age, a Mauldin Economics advisory he founded, he also brings together leading experts in longevity science and biotech investing — with quarterly council calls featuring Dr. Roizen.
Over the past decade, Mauldin’s focus has shifted toward what he sees as the most consequential economic force of our time: the convergence of longevity science and preventive medicine. That conviction led him to co-found Lifespan Edge alongside Dr. Michael Roizen — not as a passive investor, but as an active builder determined to bring clinically proven therapies to the people who need them. He currently lives in Puerto Rico and is the proud father of seven children, five of whom are adopted.
I discovered something my dad never had access to — a breakthrough therapy that has given me more time, more health, and more memories with the people I love.
John Mauldin, Co-Founder of Lifespan Edge
Background
Built on three decades at the intersection of economics and foresight.
Published Works
Six books, four NYT bestsellers
Including Endgame, Code Red, and Bull’s Eye Investing — translated into Chinese, Spanish, and Italian.
Longevity Research
Founder, Transformative Age
Mauldin Economics’ biotech and longevity advisory — combining healthspan science with investment strategy. Features quarterly council calls with Dr. Mike Roizen, connecting the Lifespan Edge medical team directly to the investor community.
Newsletter
Thoughts from the Frontline
One of the first free investment newsletters. Today read by over 1 million people weekly in multiple languages worldwide.
Business Leadership
Co-founder, Mauldin Economics
A research platform providing institutional-level macroeconomic analysis and actionable investment strategies to hundreds of thousands of readers.
Annual Convening
Strategic Investment Conference
Hosts world-class economists and analysts including Mohamed El-Erian, Niall Ferguson, David Rosenberg, and Jeffrey Gundlach.
Media
CNBC, Bloomberg TV, Financial Times
A regular presence in national financial media and sought-after speaker at investment conferences worldwide.
Published Works
Selected bibliography
NYT #1
Endgame: The End of the Debt Supercycle and How It Changes Everything
With Jonathan Tepper. A prescient analysis of sovereign debt crises and their cascading economic consequences.
NYT #1
Code Red: How to Protect Your Savings from the Coming Crisis
With Jonathan Tepper. A roadmap through the era of quantitative easing, zero interest rates, and currency wars.
bestseller
Bull’s Eye Investing: Targeting Real Returns in a Smoke and Mirrors Market
A contrarian guide to navigating secular bear markets and finding genuine value.
bestseller
Just One Thing: Twelve of the World’s Best Investors Reveal the One Strategy You Can’t Overlook
Curated wisdom from a dozen elite investors, each sharing their single most important principle.
At Lifespan Edge
From forecasting the future to building it.
John Mauldin has spent his career studying the forces that reshape economies and societies. In longevity science, he found one that dwarfs all others in scope: the possibility of extending healthy human life by decades, not years.
At Lifespan Edge, Mauldin brings the same rigor he applies to macroeconomic analysis — identifying what the data actually shows, separating proven science from hype, and building the operational infrastructure to deliver it at scale. Alongside co-founder Dr. Michael Roizen, he is focused on making therapeutic plasma exchange and evidence-based longevity medicine available to patients who refuse to wait for the future to arrive on its own.
His role is what it has always been: seeing where the curve is bending, and getting there first.